Research
Education
Healthcare
Community
About
Jan 01, 2023 | The Lancet Neurology
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
A new study delves into the brains of individuals with different Alzheimer's risk factors, comparing the timing and location of protein deposits linked to memory loss. This research could unlock key differences in disease progression and offer valuable insights for future treatments.
Sep 26, 2022 | UC Irvine News
UCI awarded $13.8 million federal contract to profile lipid nanoparticles
Findings will increase understanding of vaccine immune responses and side effects.
Sep 22, 2022 | UC Irvine News
UCI is key member of multi-institutional, $126 million NIH brain mapping project
Campus to receive $10 million over five years for role in Cell Atlas Network
Sep 19, 2022 | UC Irvine News
Precision health perspectives
Daniel Chow discusses how physicians can use artificial intelligence tools to benefit patients
Jul 06, 2022 | UC Irvine School of Medicine
UCI researcher leads study linking ALS to immune and central nervous systems
Findings show promise of bone marrow transplants as novel treatment approach
Jun 07, 2022 | UC Irvine News
UCI wins 5-year, $14M NIH grant to study brain circuits susceptible to aging, Alzheimer’s disease
Findings will advance development of better early diagnostic tools, new treatment strategies
Apr 11, 2022 | UC Irvine School of Medicine
New study from UCI reveals how to rejuvenate the immune system of elderly people and reduce their risk of infectious disease
Results identify reason for why older adults are significantly more susceptible to infectious diseases.
Jan 11, 2022 | UC Irvine School of Medicine
UCI-led research team discovers a molecular feature in prostate cancer with prognostic value, distinguishes ancestral differences
Expression signatures may be useful for assessing greatest risk of progression in prostate and other cancers
Oct 22, 2020 | UC Irvine School of Medicine
NIH Awards Over $100 Million to Examine Biomarkers of Alzheimer’s Disease in Adults with Down Syndrome
The Alzheimer’s Biomarkers Consortium – Down Syndrome (ABC-DS), a multi-institution research team, co-led by members from the University of California, Irvine, has been awarded an unprecedented five-year, $109 million grant by the National Institutes of Health (NIH), to expand research on the biomarkers of Alzheimer’s disease in adults with Down syndrome.
Mar 23, 2020 | UC Irvine School of Medicine
UCI researcher receives $3.5 million grant to study older adults diagnosed with dementia
Study will examine hippocampal sclerosis (HS) that often mimics Alzheimer's